Sobre a EDCTP

We are in the process of launching our new website. Please come back later to check it out.

A Parceria entre a Europa e os Países em Desenvolvimento para a Realização de Ensaios Clínicos (EDCTP) tem por objectivo acelerar o desenvolvimento de fármacos, vacinas, microbicidas e diagnósticos novos ou melhorados para o VIH/SIDA, a tuberculose e a malária, com particular incidência em ensaios clínicos da fase II e III na África subsaariana.

Portuguese title

Descubra a estratégia da EDCTP na luta contra HIV/AIDS, tuberculose e malária.

Leia mais

Portuguese title

Descubra a estratégia da EDCTP na luta contra HIV/AIDS, tuberculose e malária.

Leia mais

Portuguese title

Descubra a estratégia da EDCTP na luta contra HIV/AIDS, tuberculose e malária.

Leia mais

Latest news

11 December 2019

PanACEA 2: New TB drug tested in patients for the first time in South Africa

The new promising tuberculosis drug BTZ-043 has been administered to patients for the first time in Cape Town, South Africa. This clinical study which is led by Professor Michael Hoeslcher of the Tropical Institute at the Hospital of the Ludwig-Maximilians…

Read more
2 December 2019

World AIDS day 2019: Clinical research that reaches key populations

According to World Health Organization (WHO) statistics, in 2018 an estimated 1.7 million people were newly infected with HIV and there were 0.8 million HIV-related deaths. Most of these deaths are in low and middle-income countries, particularly in sub-Saharan Africa,…

Read more